Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome-Reference-Cited by-同舟云学术

Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome

Published:2019-07-31 Issue:18 Volume:6 Page:1901441
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Zheng Peng¹²³,Li Yifan¹²³,Wu Jing⁴,Zhang Hanping¹²³,Huang Yu¹²³,Tan Xunmin¹²³,Pan Junxi⁴,Duan Jiajia⁴,Liang Weiwei⁴,Yin Bangmin⁴,Deng Fengli⁵,Perry Seth W.⁶,Wong Ma‐Li⁶,Licinio Julio⁶,Wei Hong⁷,Yu Gang¹,Xie Peng¹²³^ORCID

Affiliation:

1. Department of NeurologyThe First Affiliated Hospital of Chongqing Medical University Chongqing 400016 China

2. Institute of Neuroscience and the Collaborative Innovation Center for Brain ScienceChongqing Medical University Chongqing 400016 China

3. NHC Key Laboratory of Diagnosis and Treatment on Brain Function and Disease Chongqing 400016 China

4. The M.O.E. Key Laboratory of Laboratory Medical Diagnosticsthe College of Laboratory MedicineChongqing Medical University Chongqing 400016 China

5. Social Medicine and Health ManagementChongqing Medical University Chongqing 400016 China

6. Department of PsychiatryCollege of MedicineSUNY Upstate Medical University Syracuse NY 13210 USA

7. Precision Medicine InstituteThe First Affiliated HospitalSun Yat‐sen University Guangzhou Guangdong 510080 China

Funder

National Basic Research Program of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201901441

Reference45 articles.

1. Myasthenia Gravis

2. Myasthenia gravis — autoantibody characteristics and their implications for therapy

3. Myasthenia gravis: new developments in research and treatment

4. Autoimmune synaptopathies

5. Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis;Computational and Structural Biotechnology Journal;2024-12

2. Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4+ T cells and modulating gut microbiota;International Immunopharmacology;2024-09

3. Treatment response of venlafaxine induced alterations of gut microbiota and metabolites in a mouse model of depression;Metabolic Brain Disease;2024-08-16

4. Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy;Autoimmunity Reviews;2024-07

5. Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine;Frontiers in Psychiatry;2024-06-13